Studies on dipeptidyl aminopeptidase IV(DAP IV) in human peripheral lymphocytes.
スポンサーリンク
概要
- 論文の詳細を見る
Dipeptidyl aminopeptidase IV (DAP IV) has been demonstrated localizing in certain human T cell. In vitro mitogen stimulations (PHA, Con A and PWM) was employed to assess possible participation of lymphocyte DAP IV in immune responses.In healthy human peripheral lymphocytes, mitogen stimulations produced a marked increase in DAP IV activities; and similar increase was observed also in culture supernatant. In addition, those phenomena paralleled with increase in released soluble IL-2 receptor.The principal action of DAP IV remained unknown, but it might, with its connection to production of IL-2 receptor, be part of a correlating mechanism having to do with an immune regulatory system.Clinical data from the patients with Behcet's disease, rheumatoid arthritis and systemic lupus erythematosus were discussed in a comparable manner.
- 日本臨床免疫学会の論文
著者
関連論文
- 3. アトピー性皮膚炎の東洋医学的治療とその評価 (16 アレルギー病の漢方治療)
- 2-I-34 ベーチェット病のCiclosporin療法における血清脂質およびビタミンEの役割(第38回大会研究発表要旨,日本ビタミン学会)
- Behcet病におけるUhthoff症状(現象)
- Analysis of Urinary Catecholamines Using High-performance Reversed-phase Chromatography with Electrochemical Detection; Methodology of Available Extraction of Catecholamines from Urine.
- Studies on dipeptidyl aminopeptidase IV(DAP IV) in human peripheral lymphocytes.